Disease Biomarkers
Disease biomarker research uses metabolomics to identify measurable small-molecule signatures associated with disease biology, diagnosis, prognosis, treatment response, and precision medicine.
Research Overview
Metabolic biomarkers provide direct insight into biochemical activity because metabolites reflect cellular function, physiological state, environmental exposure, and disease-associated pathway disruption. Disease biomarker discovery uses metabolite profiles to identify molecular patterns that distinguish health, disease, progression, and therapeutic response.
At PanorOmics, disease biomarkers are presented as a core metabolomics research area: a translational bridge between metabolite measurement, disease mechanisms, clinical interpretation, precision medicine, and multi-omics biomarker discovery.
Core Research Areas
Metabolic Disease Signatures
Identifying metabolite patterns associated with disease presence, progression, severity, and biological dysfunction.
Clinical Metabolomics
Applying metabolite analysis to patient samples, translational research, diagnostics, prognosis, and precision medicine studies.
Biomarker Validation
Evaluating candidate metabolic biomarkers across cohorts, sample types, analytical platforms, and clinical contexts.
Multi-omics Biomarker Integration
Combining metabolomics with genomics, transcriptomics, proteomics, lipidomics, and clinical data to improve disease interpretation.
Disease Biomarker Technologies
Mass Spectrometry
High-sensitivity analytical technology used to detect, quantify, and characterize metabolites across biological samples.
LC-MS / MS
Liquid chromatography coupled with mass spectrometry for broad metabolite detection and disease biomarker discovery.
GC-MS
Gas chromatography mass spectrometry used for volatile, derivatized, and small-molecule metabolite analysis.
NMR Spectroscopy
Non-destructive metabolite measurement approach used for reproducible metabolic profiling and biomarker studies.
AI-Assisted Metabolomics
Machine learning approaches that support biomarker signature discovery, disease classification, and metabolic interpretation.
Disease Biomarker Modalities
Discovery Metabolomics
Broad, unbiased profiling used to identify candidate metabolites associated with disease or biological state.
Targeted Biomarker Panels
Focused measurement of selected metabolites for validation, monitoring, or clinical translation.
Plasma and Serum Metabolomics
Blood-based metabolite profiling used to discover circulating disease biomarkers.
Urine Metabolomics
Non-invasive metabolite profiling used for disease monitoring, exposure assessment, and biomarker discovery.
Tissue Metabolomics
Metabolic analysis of tissue samples to identify disease-associated biochemical alterations.
Longitudinal Biomarker Monitoring
Tracking metabolite changes over time to study disease progression, treatment response, or recovery.
Related metabolomic approaches such as metabolite profiling, metabolic phenotyping, and pathway analysis are explored across the Metabolomics Research Center.
Landmark Disease Biomarker Milestones
Clinical Chemistry Foundations
Routine measurement of small molecules in blood and urine established the clinical value of metabolites as disease indicators.
Inborn Errors of Metabolism
Metabolite testing became central to diagnosing inherited metabolic disorders and understanding biochemical disease mechanisms.
Metabolomics Era Emerges
High-throughput metabolite profiling expanded disease biomarker discovery beyond individual metabolites toward metabolic signatures.
Mass Spectrometry Biomarker Discovery
LC-MS, GC-MS, and related technologies enabled sensitive discovery of disease-associated metabolites across clinical samples.
Systems Metabolomics
Metabolic biomarker studies increasingly connected metabolites with pathways, phenotypes, exposures, and disease mechanisms.
Multi-omics Disease Biomarkers
Integrated omics approaches combine metabolite signatures with genomic, transcriptomic, proteomic, lipidomic, and clinical data.
AI-Assisted Disease Biomarker Discovery
AI increasingly supports metabolic biomarker discovery, patient stratification, disease classification, and precision medicine research.
Featured Publications
Metabolomics: The Link Between Genotypes and Phenotypes
The Human Metabolome Database
Metabolomics and Disease Biomarker Discovery
Mass Spectrometry-Based Metabolomics
Metabolomics in Precision Medicine
Multi-omics Biomarker Discovery
Continue Your Research Journey
Metabolite Profiling →
Continue exploring the Metabolomics Research Center.
Metabolic Phenotyping →
Continue exploring the Metabolomics Research Center.
Pathway Analysis →
Continue exploring the Metabolomics Research Center.